Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: Correlations with in vitro and in vivo chemoresponses

Blood

Volumn 91, Issue 9, 1998, Pages 3379-3389

  Kitada, Shinichi ^b   Andersen, Janet ^b   Akar, Sophie ^b   Zapata, Juan M ^b   Takayama, Shinichi ^b   Krajewski, Stanislaw ^b   Wang, Hong Gang ^b   Zhang, Xin ^b   Bullrich, Florencia ^b   Croce, Carlo M ^b   Rai, Kanti ^b   Hines, John ^b   Reed, John C ^a  

^a BURNHAM INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMBUCIL; FLUDARABINE;

APOPTOSIS; ARTICLE; CANCER STAGING; CELL CYCLE G1 PHASE; CELL DEATH; CELL SURVIVAL; CHEMOSENSITIVITY; CHROMOSOME TRANSLOCATION; CHRONIC LYMPHATIC LEUKEMIA; DRUG EFFECT; GENE REARRANGEMENT; HUMAN; HUMAN CELL; MOLECULAR CLONING; PRIORITY JOURNAL; PROTEIN EXPRESSION; THROMBOCYTE COUNT;

EID: 0032079746     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.9.3379     Document Type: Article

References (51)

1. Wingo PA. Tong T, Bolden S: Cancer statistics. 1995. CA, Cancer J Clinicians 45:8, 1995
2. Montserrat E, Binet JL, Dighiero G. Gale RP, Juliusson G, Keating M, Rai KR: Chronic lymphoproliferative disorders. Rev Invest Clin 52:8, 1994 (suppl)
3. O'Brien S, del Giglio A, Keating M: Advances in the biology and treatment of B-cell chronic lymphocytic leukemia. Blood 85:307, 1995
4. Caligaris-Cappio F: B-chronic lymphocytic leukemia: A malignancy of anti-self B cells. Blood 87:2615, 1996
5. Dighiero G, Travade P, Chevret S, Fenaux P, Chastang C, Binet J-L: B-cell chronic lymphocytic leukemia: Present status and future directions. Blood 78:1901, 1991
6. Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O'Brien S, Rai KR: National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: Revised guidelines for diagnosis and treatment. Blood 87:4990, 7, 1996
7. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1, 1994
8. Yang E, Korsmeyer SJ: Molecular thanatopsis: A discourse on the Bcl2 family and cell death. Blood 88:386, 1996
9. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267:1456, 1995
10. McConkey DJ, Chandra J, Wright S, Plunkett W, McDonnell TJ, Reed JC, Keating M: Apoptosis sensitivity in chronic lymphocytic leukemia is determined by endogenous endonuclease content and relative expression of BCL-2 and BAX. J Immunol 156:2624, 1996
11. Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC: bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 82:1820, 1993
12. Schena M, Larsson LG, Gottardi D, Gaidano G, Carlsson M, Nilsson K, Caligaris-Cappio F: Growth- and differentiation-associated expression of bcl-2 in B-chronic lymphocytic leukemia cells. Blood 79:2981, 1992
13. Thomas A, El Rouby S, Reed JC, Krajewski S, Potmesil M, Newcomb EW: Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: Relationship of p53 gene mutation, bcl-2/bax proteins in drug resistance. Oncogene 12:1055, 1996
14. Mentz F, Mossalayi MD, Ouaaz F, Baudet S, Issaly F, Ktorza S, Semichon M, Binet J-L, Merle BH: Theophylline synergizes with chlorambucil in inducing apoptosis of B-chronic lymphocytic leukemia cells. Blood 88:2172, 1996
15. Pepper C, Bentley P, Hoy T: Regulation of clinical chemoresistance by bcl-2 and bax oncoproteins in B-cell chronic lymphocytic leukaemia. Br J Haematol 95:513, 1996
16. + B cells the expression of BCL-2 gene family is shifted toward protection from apoptosis. Br J Haematol 94:612, 1996
17. Raghoebier S, van Krieken JH, Kluin-Nelemans JC, Gillis A, van Ommen GJ, Ginsberg AM, Raffeld M, Kluin PM: Oncogene rearrangements in chronic B-cell leukemia. Blood 77:1560, 1991
18. Rechavi G, Katzir N, Brok-Simoni F, Holtzman F, Mandel M, Gurfinkel N, Givol D, Ben-Bassat I, Ramot B: A search for bcl1, bcl2, and c-myc oncogene rearrangements in chronic lymphocytic leukemia. Leukemia 3:57, 1989
19. Reed JC: Bcl-2: Prevention of apoptosis as a mechanism of drug resistance. Hematol Oncol Clin North Am 9:451, 1995
20. Goodman MG, Spinosa JC, Saven A, Piro LD, Wormsley S: New perspectives on the approach to chronic lymphocytic leukemia. Leuk Lymphoma 22:1, 1996
21. O'Brien S, Kantarjian H, Beran M, Smith T, Koller C, Estey E, Robertson LE, Lerner S, Keating M: Results of fludarabine and prednisone therapy in 264 patients with chronic lymphocytic leukemia with multivariate analysis-derived prognostic model for response to treatment [see comments]. Blood 82:1695, 1993
22. Robertson LE, Plunkett W, McConnell K, Keating MJ, McDonnell TJ: Bcl-2 expression in chronic lymphocytic leukemia and its correlation with the induction of apoptosis and clinical outcome. Leukemia 10:456, 1996
23. Aguilar-Santelises M, Rottenberg ME, Lewin N, Mellstedt H, Jondal M: Bcl-2, Bax, and p53 expression in B-cell in relation to in vitro survival and clinical progression. Int J Cancer 69:114, 1996
24. Pepper C, Hoy T, Bentley DP: Bcl-2/Bax ratios in chronic lymphocytic leukaemia and their correlation with in vitro apoptosis and clinical resistance. Br J Cancer 76:935, 1997
25. Reed JC: Double identity for proteins of the Bcl-2 family. Nature 387:773, 1997
26. Takayama S, Sato T, Krajewski S, Kochel K, Irie S, Millan JA, Reed JC: Cloning and functional analysis of BAG-1: A novel Bcl-2 binding protein with anti-cell death activity. Cell 80:279, 1995
27. Fernandes-Alnemri T, Litwack G, Alnemri ES: CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem 269:30761, 1994
28. Martin SJ, Green DR: Protease activation during apoptosis: Death by a thousand cuts? Cell 82:349, 1995
29. Krajewski S, Gascoyne RD, Zapata JM, Krajewska M, Kitada S, Chhanabhai M, Horsman D, Berean K, Piro LD, Fugier-Vivier I, Liu YJ, Wang HG, Reed JC: Immunolocalization of the ICE/Ced-3-family protease, CPP32 (Caspase-3), in non-Hodgkin's lymphomas (NHLs), chronic lymphocytic leukemias (CLL), and reactive lymph nodes. Blood 89:3817, 1997
30. Rai KR, Peterson D, Elias L, Shepherd L, Hines J, Nelson D, Cheson B, Kolitz J, Schiffer CA: A randomized comparison of fludarabine and chlorambucil for patients with previously untreated chronic lymphocytic leukemia. A CALGB, SWOG, CTG/NCI-C and ECOG inter-group. Blood 88:141a, 1996
31. Krajewski S, Zapata JM, Reed JC: Detection of multiple antigens on Western blots. Anal Biochem 236:221, 1996
32. Sato T, Irie S, Kitada S, Reed JC: FAP-1: A protein tyrosine phosphatase that associates with Fas. Science 268:411, 1995
33. Bullrich F, Veronese ML, Kitada S, Jurlander J, Caligiuri MA, Reed JC, Croce CM: Minimal region of loss at 13q14 in B-cell chronic lymphocytic leukemia. Blood 88:3109, 1996
34. Krajewski S, Bodrug S, Gascoyne R, Berean K, Krajewska M, Reed JC: Immunohistochemical analysis of mcl-1 and bcl-2 proteins in normal and neoplastic lymph nodes. Am J Pathol 145:515, 1994
35. Krajewski S, Bodrug S, Krajewska M, Shabaik A, Gascoyne R, Berean K, Reed JC: Immunohistochemical analysis of Mcl-1 protein in human tissues: Differential regulation of Mcl-1 and Bcl-2 protein production suggests a unique role for Mcl-1 in control of programmed cell death in vivo. Am J Pathol 146:1309, 1995
36. Kitada S, Krajewska M, Zhang X, Scudiero D, Zapata JM, Wang H-G, Shabik A, Tudor G, Krajewski S, Myers TG, Johnson GS, Sausville EA, Reed JC: Expression and location of pro-apoptotic Bcl-2 family protein BAD in normal human tissues and tumor cell lines. Am J Pathol 152:51, 1998
37. Molica S: Progression and survival studies in early chronic lymphocytic leukemia. Blood 78:895, 1991
38. Keating M, Cheson B, Gribben JG, Robertson B, Nadler L: Innovative strategies for the treatment of CLL. Leuk Lymphoma 22:53, 1996 (suppl 2)
39. Gorczyca W, Bruno S, Darzynkiewicz RJ, Gong J, Darzynkiewicz Z: DNA strand breaks occurring during apoptosis: Their early in situ detection by the terminal deoxynucleotidyl transferase and nick translation assays and prevention by serine protease inhibitors. Int J Oncol 1:639, 1992
40. Garrone P, Neidhardt-Berard E-M, Garcia E, Durand I, Salles G, Coiffier B, Banchereau J: B-Chronic lymphocytic leukemia cells display reduced susceptibility to Fas-induced apoptosis. Blood 1998 (in press)
41. Douglas RS, Capocasale RJ, Lamb RJ. Nowell PC, Moore JS: Chronic lymphocytic leukemia B cells are resistant to the apoptotic effects of transforming growth factor-beta. Blood 89:941, 1997
42. Robertson LE, Chubb S, Meyn RE, Story M, Ford R, Hittelman WN, Plunkett W: Induction of apoptotic cell death in chronic lymphocytic leukemia by 2-chloro-2′-deoxyadenosine and 9-beta-D-arabinosyl-2-fluoroadenine, Blood 81:143, 1993
43. O'Brien S, Kantarjian H, Estey E, Koller C, Robertson B, Beran M, Andreeff M, Pierce S, Keating M: Lack of effect of 2-chlorodeoxyadenosine therapy in patients with chronic lymphocytic leukemia refractory to fludarabine therapy [see comments]. N Engl J Med 330:319, 1994
44. Lømo J, Smeland EB, Krajewski S, Reed JC, Blomhoff HK: Involvement of the Bcl-2 homolog Mcl-1 in the regulation of apoptosis in peripheral blood B lymphocytes. Cancer Res 56:40, 1996
45. Wang S, Rowe M, Lundgren E: Expression of the Epstein Barr virus transforming protein LMP1 causes a rapid and transient stimulation of the Bcl-2 homologue Mcl-1 levels in B-cell lines. Cancer Res 56:4610, 1996
46. Reynolds JE, Li J, Craig RW, Eastman A: Bcl-2 and mcl-1 expression in Chinese hamster ovary cells inhibits intracellular acidification and apoptosis induced by staurosporine. Exp Cell Res 225:430, 1996
47. Reynolds JE, Yang T, Qian L, Jenkinson JD, Zhou P, Eastman A, Craig RW: Mcl-1 a member of the Bcl-2 family, delays apoptosis induced by c-Myc overexpression in Chinese hamster ovary cells. Cancer Res 54:6348, 1994
48. Bodrug SE, Aimé-Sempé C, Sato T, Krajewski S, Hanada M, Reed JC: Biochemical and functional comparisons of Mcl-1 and Bcl-2 proteins: Evidence for a novel mechanism of regulating Bcl-2 family protein function. Cell Death Diff 2:173, 1995
49. Sato T, Hanada M, Bodrug S, Irie S, Iwama N, Boise LH, Thompson CB, Golemis E, Fong L, Wang H-G, Reed JC: Interactions among members of the bcl-2 protein family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci USA 91:9238, 1994
50. Yang T, Kozopas KM, Craig RW: The intracellular distribution and pattern of expression of Mcl-1 overlap with, but are not identical to, those of Bcl-2. J Cell Biol 128:1173, 1995
51. Breiman L, Friedman JH, Olshen RA, Stone CJ: Classification and Regression Trees. Belmont, CA, Wadsworth International Group, 1984